Next tier of markets is poised to ascend and offer valuable opportunities to both investors and occupiers.
JLL, a global commercial real estate services company, has released its Emerging Life Sciences Markets Index. The report evaluates metro areas with respect to a wide variety of metrics chosen to best reflect the most critical qualities of life sciences markets on the upswing.
Examining 110 US markets, the index highlights where life sciences jobs are growing the most as well as what markets are accelerating and keeping a full pipeline of talent. The result of this research is a three-pronged model:
For more information and the full report, click here.
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.